RxDoctor Payments Data

Cassandra Key

Internal Medicine · San Antonio, TXNPI 1568645638

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 1 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Every reported general payment came from a single manufacturer, Organon. That places this record below the midpoint for internal medicine clinicians in TX, where the typical reported total is $270.

$25in general payments, 2019–2025

Across 1 payment — averaging $24.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organon$25
$5,563,821in research payments, 2019–2025

Across 175 payments — averaging $31,793 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • GSK$1.6M
  • Amphastar Pharmaceuticals, Inc.$1.4M
  • Halozyme Inc$1M
  • Novo Nordisk AS$640K
  • AMAG Pharmaceuticals, Inc.$629K
  • Eli Lilly$206K
  • plus $20K from 3 others

What the payments were for

  • Food & beverage$25100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Organon1$25

How this compares

$25 in reported general payments places this provider in the 15th percentile of 7,675 internal medicine providers in Texas.

See all internal medicine providers in Texas

Other internal medicine in San Antonio

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →